Nektar Therapeutics
Pharmaceutical Preparations · San Francisco, CA, United States
- PrincipalsHoward W RobinPresident & CEOMark Andrew WilsonChief Legal OfficerJonathan ZalevskyChief R&D Officerand 5 more
- CompanyNektar TherapeuticsSan Francisco, CA, United States
- Phone line+1 (415) 482-5300General business
Nektar Therapeutics is an SEC-registered Nasdaq-listed company (ticker NKTR) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 8
Chief executive
Howard W RobinPresident & CEO
Chair & board
Diana BrainardDirector (Board)
Jeffrey Robert AjerDirector (Board)
R Scott GreerDirector (Board)
Robert ChessDirector (Board)
Technology & engineering
Jonathan ZalevskyChief R&D Officer
Legal
Mark Andrew WilsonChief Legal Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Howard W Robin — President & CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jonathan Zalevsky — Chief R&D Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Mark Andrew Wilson — Chief Legal Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Diana Brainard — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Kiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityQuantum Cyber N.V.Pharmaceutical Preparations · Mainz1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityuniQure N.V.Pharmaceutical Preparations · Amsterdam1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityKazia Therapeutics LtdPharmaceutical Preparations · Sydney Nsw1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capability